ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980

In Brief: Children’s Hospital Of Boston Names Pizzo Physician-In-chief; Lynch Wins Bristol Award

March 22, 1996

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

ONS Again Offers Nursing Certification Exam In May, Sept

January 11, 1991

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009